2025-03-12 13:10:28
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Windlas Biotech Ltd Q4FY22 consolidated profit rises to Rs. 14.78 crores
Posted On : 2022-05-13 16:44:45( TIMEZONE : IST )
Windlas Biotech Ltd has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 125.136 crores during the period ended March 31, 2022 as compared to Rs. 119.384 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 14.788 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 8.314 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 6.97 for the period ended March 31, 2022 as compared to Rs. 3.81 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 125.136 crs | ₹119.384 crs |  4.82% |
| Net Profit | ₹14.788 crs | ₹8.314 crs | 77.87% |
| EPS | ₹6.97 | ₹3.81 | 82.94% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 125.136 crores during the period ended March 31, 2022 as compared to Rs.107.601 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.14.788 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.5.896 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.6.97 for the period ended March 31, 2022 as compared to Rs.3.24 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 125.136 crs | ₹107.601 crs | 16.30% |
| Net Profit | ₹14.788 crs | ₹5.896 crs | 150.81% |
| EPS | ₹6.97 | ₹3.24 | 115.12% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.472.636 crores during the Financial Year ended March 31, 2022 as compared to Rs.430.695 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.38.089 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.15.832 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.18.58 for the Financial Year ended March 31, 2022 as compared to Rs.8.70 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹472.636 crs | ₹430.695 crs | 9.74% |
| Net Profit | ₹38.089 crs | ₹15.832 crs | 140.58% |
| EPS | ₹18.58 | ₹8.70 | 113.56% |
Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 215.50 as compared to the previous close of Rs. 218.55. The total number of shares traded during the day was 18476 in over 518 trades.
The stock hit an intraday high of Rs. 220.65 and intraday low of 214.00. The net turnover during the day was Rs. 4003228.00.
